Staying ahead of the competition is critical in every sector, particularly in the dynamic healthcare space, where a single ...

Acquisition includes CAPLYTA ® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of ...

Under the influence of “holotropic breathwork,” your brain may be making its own psychedelic compound.

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.

A Missouri man who crashed a rental truck into barriers protecting the White House has been sentenced to eight years in ...

You do it for us.” Shafter added that while he lives in CdN, he told Mayor Mitchell Brownstein and the council that “you are ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.

We’re warned that sleeplessness takes a serious toll. But obsessing over how to cure it may be even more damaging.

Discover how to navigate inflation with long-term investments in resilient companies like Coca-Cola, AbbVie, and TC Energy. Read more about our stock picks on Seeking Alpha.

Q4 2024 Results Conference Call January 23, 2025 10:00 AM ETCompany ParticipantsJim Eccher - Chairman, President ...

We think Roche's drug portfolio and industry-leading diagnostics conspire to create maintainable competitive advantages. As the market leader in both biotech and diagnostics, this Swiss healthcare ...

The once-promising drug was a potential blockbuster for treating schizophrenia, and was the primary motive for the $8.7 billion Cerevel Therapeutics deal. Analysts have revised their long-term ...